| Authors: |
Danilov AV; Department of Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Coombs CC; Department of Medicine, University of California Irvine School of Medicine, Irvine, California, USA., Phillips T; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, California, USA., Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Barrientos JC; Columbia University Division of Hematology/Oncology, Mount Sinai Medical Center, Miami Beach, Florida, USA., Barta SK; Division Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Choi MY; Sanford Stem Cell Institute and Division of Hematology/Oncology, University of California San Diego, San Diego, California, USA., Cohen JB; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA., Hill BT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Karmali R; Department of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Patel K; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Rhodes JM; Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute, New Brunswick, New Jersey, USA., Sauter C; Adult Bone Marrow Transplant and Cell Therapy Services, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Strati P; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Shadman M; Fred Hutchinson Cancer Center, University of Washington Medicine, Seattle, Washington, USA. |
